MESONDLY
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

MESONDLY Trademark

Serial Number: 99031402

MESONDLY is a trademark filed by Regeneron Pharmaceuticals, Inc. on February 6, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Regeneron Pharmaceuticals, Inc. (22 trademarks)

777 Old Saw Mill River Road
Tarrytown, NY 10591

Entity Type: 03

Trademark Details

Filing Date

February 6, 2025

Registration Date

Not Registered

Published for Opposition

August 26, 2025

Goods & Services

Pharmaceutical preparations for the treatment of auditory, hematological, gastrointestinal, neuromuscular, muscular, cardiovascular, metabolic, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, viral, and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of obesity; pharmaceutical preparations for immunotherapy treatment, cell therapy, and gene therapy

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 20, 2026 EXRA
SOU EXTENSION 1 GRANTED
Apr 20, 2026 EX1G
SOU EXTENSION 1 FILED
Apr 20, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 20, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 21, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 26, 2025 NPUB
PUBLISHED FOR OPPOSITION
Aug 26, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 20, 2025 NONP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 25, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 25, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 25, 2025 REAP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 16, 2025 CNSA
ASSIGNED TO EXAMINER
Jul 15, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 6, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Feb 6, 2025 MAFR
NEW APPLICATION ENTERED
Feb 6, 2025 NWAP